Drugs / Yangxue Qingnao Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06344312 | Jan 2024 → Jan 2025 | ischemic stroke | Peking University Third Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yangxue Qingnao Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06344312 ↗ |
| Route | Oral | “Randomly take 2 bags of Yangxue Qingnao Granules orally during intravenous thrombolysis with ateplase” NCT06344312 ↗ |